GALT
Galectin Therapeutics Inc
3.70$
+1.1%
vs. previous close
Closing price · As of: Sep 17, 2026
Filings
Filings
Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Galectin Therapeutics Inc (GALT) with date, type and a link to the original document.
| Date | Type | Filing | Original |
|---|---|---|---|
| 08/14/2026 | Current report (8-K) | GALECTIN THERAPEUTICS INC (GALT): Results of Operations and Financial Condition; Financial Statements and Exhibits | View report ↗ |
| 08/04/2026 | Current report (8-K) | GALECTIN THERAPEUTICS INC (GALT): Unregistered Sales of Equity Securities; Financial Statements and Exhibits | View report ↗ |
Showing the 100 most recent filings of the selected type.
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.